| scholarly article | Q13442814 |
| P50 | author | Katherine Payne | Q39186054 |
| P2093 | author name string | Fiona Ulph | |
| Susanne Georgsson | |||
| Katherine Payne | |||
| Caroline M Vass | |||
| P2860 | cites work | Update on Procedure-Related Risks for Prenatal Diagnosis Techniques | Q22241937 |
| Antenatal screening and its possible meaning from unborn baby's perspective | Q24798963 | ||
| Stated Preference for Cancer Screening: A Systematic Review of the Literature, 1990-2013 | Q27692660 | ||
| Re-conceptualizing risk in genetic counseling: implications for clinical practice | Q30385147 | ||
| Evaluation of preferences of women and healthcare professionals in Singapore for implementation of noninvasive prenatal testing for Down syndrome. | Q33809800 | ||
| Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down's syndrome using cell free fetal DNA in the UK National Health Service | Q35142853 | ||
| Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis | Q35209735 | ||
| Preferences for Prenatal Tests for Cystic Fibrosis: A Discrete Choice Experiment to Compare the Views of Adult Patients, Carriers of Cystic Fibrosis and Health Professionals | Q35667173 | ||
| Women's birth place preferences in the United Kingdom: a systematic review and narrative synthesis of the quantitative literature | Q36098150 | ||
| Attitudes about the use of newborn dried blood spots for research: a survey of underrepresented parents | Q36671391 | ||
| Numeric, verbal, and visual formats of conveying health risks: suggested best practices and future recommendations | Q36943299 | ||
| Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units | Q37067727 | ||
| Preferences for a third-trimester ultrasound scan in a low-risk obstetric population: a discrete choice experiment | Q37333348 | ||
| Parameterising User Uptake in Economic Evaluations: The role of discrete choice experiments | Q37343876 | ||
| Preferences for prenatal tests for Down syndrome: an international comparison of the views of pregnant women and health professionals | Q37351480 | ||
| Men's experiences of antenatal screening: a metasynthesis of the qualitative research | Q38017476 | ||
| Benefits and limitations of whole genome versus targeted approaches for noninvasive prenatal testing for fetal aneuploidies | Q38101277 | ||
| Risk as an attribute in discrete choice experiments: a systematic review of the literature. | Q38190876 | ||
| Reconceptualising the external validity of discrete choice experiments. | Q38219609 | ||
| Noninvasive Prenatal Genetic Testing: Current and Emerging Ethical, Legal, and Social Issues | Q38577156 | ||
| Eliciting Preferences for Information Provision in Newborn Bloodspot Screening Programs | Q38730630 | ||
| Using Discrete Choice Experiments to Inform the Benefit-Risk Assessment of Medicines: Are We Ready Yet? | Q38768040 | ||
| A Framework for Incorporating Patient Preferences Regarding Benefits and Risks into Regulatory Assessment of Medical Technologies | Q38814096 | ||
| Prenatal screening: an ethical agenda for the near future | Q39072580 | ||
| Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 1. From blood spot to screening result | Q39622061 | ||
| Conducting discrete choice experiments to inform healthcare decision making: a user's guide. | Q40071854 | ||
| Newborn bloodspot screening in the UK--past, present and future | Q40123763 | ||
| Public Perceptions of the Benefits and Risks of Newborn Screening | Q40743222 | ||
| Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 2. From screening laboratory results to treatment, follow-up and quality assurance | Q44305585 | ||
| Informed decision making regarding antenatal screening for fetal abnormality in the United Kingdom: a qualitative study of parents and professionals | Q45027695 | ||
| Women and their partners' preferences for Down's syndrome screening tests: a discrete choice experiment. | Q45752972 | ||
| Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis | Q46945516 | ||
| Preferences for prenatal diagnosis of sickle-cell disorder: A discrete choice experiment comparing potential service users and health-care providers. | Q47152948 | ||
| Women and health care professionals' preferences for Down's Syndrome screening tests: a conjoint analysis study | Q47307138 | ||
| Provision of information about newborn screening antenatally: a sequential exploratory mixed-methods project | Q47608669 | ||
| Pregnant women's and their partners' perception of an information model on prenatal screening | Q47902331 | ||
| Using discrete choice experiments to understand preferences for quality of life. Variance-scale heterogeneity matters | Q48837726 | ||
| Audiovisual information affects informed choice and experience of information in antenatal Down syndrome screening--a randomized controlled trial | Q50186567 | ||
| A meta-synthesis of pregnant women's decision-making processes with regard to antenatal screening for Down syndrome. | Q50727861 | ||
| Non-invasive prenatal testing: ethics and policy considerations. | Q51074981 | ||
| First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation. | Q51676490 | ||
| A comparison of Australian and UK obstetricians' and midwives' preferences for screening tests for Down syndrome. | Q51826563 | ||
| [Women´s preferences for prenatal tests A discrete choice experiment to contrast noninvasive prenatal testing with current invasive tests]. | Q53082275 | ||
| Best--worst scaling: What it can do for health care research and how to do it. | Q53131959 | ||
| International perspectives on newborn screening. | Q53254323 | ||
| Women's and healthcare professionals' preferences for prenatal testing: a discrete choice experiment. | Q53621688 | ||
| Familial influences on antenatal and newborn haemoglobinopathy screening | Q55403526 | ||
| Attitudes toward prenatal screening for chromosomal abnormalities: A focus group study | Q57068865 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Understanding Midwives' Preferences for Providing Information About Newborn Bloodspot Screening | Q57148559 | ||
| Women’s and health professionals’ preferences for prenatal tests for Down syndrome: a discrete choice experiment to contrast noninvasive prenatal diagnosis with current invasive tests | Q57839583 | ||
| Chinese women's preferences for prenatal diagnostic procedure and their willingness to trade between procedures | Q58029173 | ||
| Using discrete choice experiments within a cost-benefit analysis framework: some considerations | Q80189535 | ||
| Rapid prenatal diagnostic testing for Down syndrome only or longer wait for full karyotype: the views of pregnant women | Q81624801 | ||
| Women's and health professionals' preferences for prenatal testing for Down syndrome in Australia | Q83355457 | ||
| Incorporating patient-preference evidence into regulatory decision making | Q86435897 | ||
| An Assessment of Public Preferences for Newborn Screening Using Best-Worst Scaling | Q90345326 | ||
| Preferences for prenatal testing among pregnant women, partners and health professionals | Q95529401 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| P304 | page(s) | 131 | |
| P577 | publication date | 2019-04-16 | |
| P1433 | published in | BMC Pregnancy and Childbirth | Q15750893 |
| P1476 | title | Preferences for aspects of antenatal and newborn screening: a systematic review | |
| P478 | volume | 19 |
Search more.